AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 20- 52-wk high
- $90.87
- 52-wk low
- $48.27
- Prev close
- $71.77
- Mkt cap
- $6.15B
- Fwd P/E
- 40.2x
- Beta
- 0.55
Smart money
Earnings
Earnings came in $1.09 a share above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $211.0M | $164.7M | $272.6M | $360.5M |
| Cost of what it sold | $115.9M | $16.3M | $28.0M | $19.9M |
| Gross profit | $95.1M | $148.4M | $244.5M | $340.6M |
| What it spent | ||||
| Research and development | $100.2M | $133.1M | $100.9M | $99.2M |
| Sales and admin | $84.0M | $96.9M | $86.2M | $80.6M |
| Other operating costs | -$92.2M | — | $11.6M | $11.8M |
| Total operating expenses | $92.1M | $230.0M | $198.6M | $191.6M |
| What was left | ||||
| Operating profit | $3.0M | -$81.6M | $45.9M | $149.0M |
| Interest on debt | $32.6M | $55.2M | $49.0M | $48.5M |
| Profit before tax | -$23.1M | -$139.1M | -$2.5M | $97.5M |
| Tax | -$39.0M | -$4.1M | $347.0K | $14.0M |
| Net profit | $15.9M | -$135.0M | -$2.8M | $83.5M |
| EBITDA | $20.6M | -$71.0M | $62.0M | $161.9M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
24 articles · 7 days
Coverage is bullish
Tone of tracked coverage
PTC Therapeutics (NASDAQ: PTCT) insider lines up $201,692 share sale
Leans bearishAug 17PTC Therapeutics Targets Fabry Gene Therapy in $111M Bankruptcy Auction Deal
BullishAug 16Assenagon Asset Management S.A. Has $563,000 Holdings in PTC Therapeutics, Inc. $PTCT
Leans bullishAug 16
